Porter DL - Search Results

1

Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.

Porter DL, Orloff GJ, Antin JH. Porter DL, et al. Transplant Sci. 1994 Sep;4(1):12-4; discussion 14-6. Transplant Sci. 1994. PMID: 7804691 No abstract available.

2

Non-gingival soft tissue growths after allogeneic marrow transplantation.

Woo SB, Allen CM, Orden A, Porter D, Antin JH. Woo SB, et al. Bone Marrow Transplant. 1996 Jun;17(6):1127-32. Bone Marrow Transplant. 1996. PMID: 8807125 No abstract available.

3

Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation.

Porter DL, Antin JH. Porter DL, et al. Leuk Lymphoma. 1995 Apr;17(3-4):191-7. doi: 10.3109/10428199509056823. Leuk Lymphoma. 1995. PMID: 8580787 Review.

4

Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.

Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH. Porter DL, et al. Bone Marrow Transplant. 1996 Nov;18(5):975-80. Bone Marrow Transplant. 1996. PMID: 8932854

5

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.

Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH. Porter DL, et al. N Engl J Med. 1994 Jan 13;330(2):100-6. doi: 10.1056/NEJM199401133300204. N Engl J Med. 1994. PMID: 8259165 Free article.

6

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

Collins RH Jr, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J. Collins RH Jr, et al. Among authors: porter dl. J Clin Oncol. 1997 Feb;15(2):433-44. doi: 10.1200/JCO.1997.15.2.433. J Clin Oncol. 1997. PMID: 9053463

7

Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions.

Porter DL, Antin JH. Porter DL, et al. Cancer Treat Res. 1997;77:57-85. doi: 10.1007/978-1-4615-6349-5_3. Cancer Treat Res. 1997. PMID: 9071498 Review.

8

The graft-versus-leukemia effects of allogeneic cell therapy.

Porter DL, Antin JH. Porter DL, et al. Annu Rev Med. 1999;50:369-86. doi: 10.1146/annurev.med.50.1.369. Annu Rev Med. 1999. PMID: 10073284 Review.

9

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.

Porter DL, Luger SM, Duffy KM, Stadtmauer EA, Laport G, Schuster SJ, Orloff G, Tsai D, McDaid K, Kathakali A, Leonard DG, Antin JH. Porter DL, et al. Biol Blood Marrow Transplant. 2001;7(4):230-8. doi: 10.1053/bbmt.2001.v7.pm11349810. Biol Blood Marrow Transplant. 2001. PMID: 11349810 Free article. Clinical Trial.

10

Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemia.

Porter DL, Antin JH. Porter DL, et al. Hematol Oncol Clin North Am. 1998 Feb;12(1):123-50. doi: 10.1016/s0889-8588(05)70500-1. Hematol Oncol Clin North Am. 1998. PMID: 9523229 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters